To further characterize the molecular signatures of the two tumor populations, we macro-dissected the HER2 positive tumor population from the TNBC portion and submitted each component separately for somatic tumor mutation profiling via targeted next-generation sequencing (NGS) (MSK-IMPACT7,8) after she had already completed neoadjuvant therapy and surgery. Here, ERBB2 is linked to neoplasm.